Power Law company profile

Rigel Pharmaceuticals

Biotech & Life Sciences · South San Francisco, United States · Founded 1996 · IPO 2000 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$439M

Market cap · Apr/2026

Revenue

$294M

Latest reported FY

Investors

2 investors on Rigel Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Series B+ 1 investor entered at this stage

Global footprint

Web traffic by country

11K monthly visits
across markets

🇺🇸 United States47.3%

🇨🇦 Canada20%

🇬🇧 United Kingdom17.3%

🇮🇳 India13.6%

Top 4 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo